Virtual Medicinal Product (VMP) - Loncastuximab tesirine 10mg powder for solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Loncastuximab tesirine 10mg powder for solution for infusion vials Start Date 18-12-2023 End Date
Abbreviated Name Abbreviated Name Loncastuximab tesirine 10mg inf vials Start Date 18-12-2023

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder for solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L01FX22
BNF Codes
  • BNF code 08010500
SNOMED Codes
Code Start Date End Date
42534611000001105 18-12-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Loncastuximab tesirine Based on Ingredient Substance 10 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial